S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.79%) $83.19
Gas
(-1.16%) $1.619
Gold
(-0.40%) $2 337.90
Silver
(1.02%) $27.53
Platinum
(0.65%) $928.10
USD/EUR
(-0.17%) $0.933
USD/NOK
(-0.12%) $11.01
USD/GBP
(-0.23%) $0.799
USD/RUB
(0.00%) $92.17

实时更新: Synaptogenix, Inc. [SNPX]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间27 Apr 2024 @ 04:00

2.72% $ 4.53

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):
Profile picture for Synaptogenix, Inc.

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease...

Stats
今日成交量 6 874.00
平均成交量 49 649.00
市值 4.92M
EPS $0 ( 2024-04-02 )
下一个收益日期 ( $0 ) 2024-05-20
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.150
ATR14 $0.0710 (1.57%)
Insider Trading
Date Person Action Amount type
2024-04-08 Singer William S. Buy 800 Stock Option (Right to Buy)
2024-04-08 Silverman Joshua Buy 800 Stock Option (Right to Buy)
2024-04-08 Schechter Jonathan Buy 800 Stock Option (Right to Buy)
2024-04-08 Bernstein Bruce Buy 800 Stock Option (Right to Buy)
2023-03-29 Schechter Jonathan Buy 20 000 Stock Option (Right to Buy)
INSIDER POWER
74.96
Last 71 transactions
Buy: 1 845 200 | Sell: 283 116

Synaptogenix, Inc. 相关性

10 最正相关
GOSS0.958
VORB0.946
BCAB0.946
THTX0.944
XFOR0.943
FATE0.942
NVTSW0.941
RIVN0.939
NCBS0.938
ISPO0.938
10 最负相关
NWLI-0.967
AMYT-0.967
EZGO-0.959
RXDX-0.956
TACO-0.956
MLCO-0.955
LUNA-0.954
HZNP-0.953
EXAS-0.953
MLVF-0.953

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Synaptogenix, Inc. 财务报表

Annual 2023
营收: $0
毛利润: $-6 347.00 (0.00 %)
EPS: $-12.96
FY 2023
营收: $0
毛利润: $-6 347.00 (0.00 %)
EPS: $-12.96
FY 2022
营收: $0
毛利润: $-5 714.00 (0.00 %)
EPS: $-0.780
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-2.51

Financial Reports:

No articles found.

Synaptogenix, Inc.

Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. Synaptogenix, Inc. has licensing agreements with Stanford University; Icahn School of Medicine at Mount Sinai; and The Board of Trustees of the Leland Stanford Junior University. The company was incorporated in 2012 and is headquartered in New York, New York.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。